TickerFactsScreenerDevelopers

enGene Therapeutics Inc. (ENGN) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2022: 665.8K2023: 23.20M2024: 50.98M2025: 52.02M52.02M
2022Shares Outstanding (shares)2025
Fiscal YearShares OutstandingChange YoY
202552.02M+2.0%
202450.98M+119.7%
202323.20M+3384.4%
2022665.8K—